85 related articles for article (PubMed ID: 25348738)
1. MiR-124 retards bladder cancer growth by directly targeting CDK4.
Zhang T; Wang J; Zhai X; Li H; Li C; Chang J
Acta Biochim Biophys Sin (Shanghai); 2014 Dec; 46(12):1072-9. PubMed ID: 25348738
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells.
Lin Y; Wu J; Chen H; Mao Y; Liu Y; Mao Q; Yang K; Zheng X; Xie L
FEBS Lett; 2012 Feb; 586(4):442-7. PubMed ID: 22289176
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
Huang L; Luo J; Cai Q; Pan Q; Zeng H; Guo Z; Dong W; Huang J; Lin T
Int J Cancer; 2011 Apr; 128(8):1758-69. PubMed ID: 20549700
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
[TBL] [Abstract][Full Text] [Related]
5. miR-6883 Family miRNAs Target CDK4/6 to Induce G
Lulla AR; Slifker MJ; Zhou Y; Lev A; Einarson MB; Dicker DT; El-Deiry WS
Cancer Res; 2017 Dec; 77(24):6902-6913. PubMed ID: 29061672
[TBL] [Abstract][Full Text] [Related]
6. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.
Georgantas RW; Streicher K; Luo X; Greenlees L; Zhu W; Liu Z; Brohawn P; Morehouse C; Higgs BW; Richman L; Jallal B; Yao Y; Ranade K
Pigment Cell Melanoma Res; 2014 Mar; 27(2):275-86. PubMed ID: 24289491
[TBL] [Abstract][Full Text] [Related]
8. microRNA-181a is involved in insulin-like growth factor-1-mediated regulation of the transcription factor CREB1.
Liu Y; Zhao Z; Yang F; Gao Y; Song J; Wan Y
J Neurochem; 2013 Sep; 126(6):771-80. PubMed ID: 23865718
[TBL] [Abstract][Full Text] [Related]
9. RASSF1A inhibits gastric cancer cell proliferation by miR-711- mediated downregulation of CDK4 expression.
Liao A; Tan G; Chen L; Zhou W; Hu H
Oncotarget; 2016 Feb; 7(5):5842-51. PubMed ID: 26735582
[TBL] [Abstract][Full Text] [Related]
10. miR-409-3p inhibits HT1080 cell proliferation, vascularization and metastasis by targeting angiogenin.
Weng C; Dong H; Chen G; Zhai Y; Bai R; Hu H; Lu L; Xu Z
Cancer Lett; 2012 Oct; 323(2):171-9. PubMed ID: 22531314
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.
Noguchi S; Mori T; Hoshino Y; Maruo K; Yamada N; Kitade Y; Naoe T; Akao Y
Cancer Lett; 2011 Aug; 307(2):211-20. PubMed ID: 21550168
[TBL] [Abstract][Full Text] [Related]
12. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.
Uchida Y; Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2013 Jan; 31(1):115-23. PubMed ID: 21396852
[TBL] [Abstract][Full Text] [Related]
13. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.
Bo J; Yang G; Huo K; Jiang H; Zhang L; Liu D; Huang Y
FEBS J; 2011 Mar; 278(5):786-92. PubMed ID: 21205209
[TBL] [Abstract][Full Text] [Related]
14. miR-124 radiosensitizes human esophageal cancer cell TE-1 by targeting CDK4.
Zhang YH; Wang QQ; Li H; Ye T; Gao F; Liu YC
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323123
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Wang Y; Tang Q; Li M; Jiang S; Wang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
[TBL] [Abstract][Full Text] [Related]
16. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met.
Hu Z; Lin Y; Chen H; Mao Y; Wu J; Zhu Y; Xu X; Xu X; Li S; Zheng X; Xie L
Biochem Biophys Res Commun; 2013 May; 435(1):82-7. PubMed ID: 23618864
[TBL] [Abstract][Full Text] [Related]
18. [Role of miR-206/CDK4 in modulating the growth and chemotlerapy sensitivity of ovarian cancer cells].
Ling C; Liu S; Wang Y; Zhang FC; DU Y
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):393-397. PubMed ID: 28377359
[TBL] [Abstract][Full Text] [Related]
19. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
20. miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1.
Lin Y; Chen H; Hu Z; Mao Y; Xu X; Zhu Y; Xu X; Wu J; Li S; Mao Q; Zheng X; Xie L
FEBS Lett; 2013 Aug; 587(15):2467-73. PubMed ID: 23796420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
